HomeSearch › Kathy Griesenbeck - End 7312020

Kathy Griesenbeck - End 7312020

EVP CHIEF RE at THE LEUKEMIA & LYMPHOMA SOCIETYINC · NY · Disease Research

$366K
Peak Total Compensation
1
Years Tracked
5x
vs. Median Household

Kathy Griesenbeck - End 7312020 has appeared in compensation disclosures in 2021.

Peak total compensation of $365,563 equals 5x the median U.S. household income ($75,000).

Year-by-Year Detail

Year Organization Title Compensation Other Total
2021 THE LEUKEMIA & LYMPHOMA SOCIETYINC EVP CHIEF RE $347,706 $17,857 $365,563

Peers at THE LEUKEMIA & LYMPHOMA SOCIETYINC

NameTitlePeak Comp.
Louis Jdegennaro-End 63023 PRESIDENT & CEO - FORMER $1.4M
Louis J Degennaro PRESIDENT & $1.1M
Gwen Nichols Md EVP, CHIEF MEDICAL OFC $654K
Troy Dunmire EVP, CHIEF OPERATING OFC $618K
Dale Nissenbaum EVP, GENERAL COUNSEL $544K
Gordon Miller Jr EVP, CHIEF FINANCIAL OFC $539K
Coker Powell SVP, CHIEF DEVELOPMENT OFC $506K
George J Omiros-Term Apr15 EVP-CHIEF CA $495K
E Anders Kolb - Start 512023 PRESIDENT & CEO $480K
Susan Brown SVP, CHIEF DEI OFC $471K
Email Alerts

Get notified about Kathy Griesenbeck - End 7312020

Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.


Compare with another executive: Open comparison tool →